Worth reading
21Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
46
¥100 million (year-on-year increase in operating profit)Wording
Definitive
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportFirst quarter of the fiscal year ending March 20272 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,170 million+15.2%
Operating profit¥156 million+42.7%
Results for the three months of the current quarter
Net Sales
¥1,170 million
Operating profit
¥156 million
By segmentFY2026 Q1 results for the accounting period: Chemicals, revenue of ¥62.8 billion and operating profit of ¥10.1 billion; Food, ¥21.4 billion and ¥800 million; Life Sciences, ¥31.0 billion and ¥4.4 billion; Other, ¥1.6 billion and ¥100 million, including the breakdown
What the company explained in this material
Key KPIsA metric the company considers important as a management benchmark.
- Overseas revenue ratio55.9 %Year on year against the same period last yearUp from 54.6%
- Overseas revenue¥654 millionYear on year against the same period last yearUp ¥9.9 billion year on year
- Overseas revenue in Asia¥305 millionYear on year against the same period last yearUp ¥4.6 billion year on year
- Overseas revenue in the US, Europe, the Middle East and other regions¥348 millionYear on year against the same period last yearUp ¥5.2 billion year on year
Segment results
Chemicals
Net Sales
¥628 million+20.0%
Operating profit
¥101 million+60.9%
Resin additives
Net Sales
¥287 million+14.5%
Operating profit
¥38 million+49.0%
Semiconductor Materials
Net Sales
¥108 million+47.2%
Operating profit
¥26 million+82.9%
Environmental materials
Net Sales
¥232 million+16.9%
Operating profit
¥35 million+60.1%
Food
Net Sales
¥214 million+4.2%
Operating profit
¥8 million-21.6%
Life Science
Net Sales
¥310 million+14.6%
Operating profit
¥44 million+36.9%
Other
Net Sales
¥16 million+9.9%
Operating profit
¥1 million-38.4%
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥1,170 million (YoY +15.2%) |
| Operating profit | ¥156 million (YoY +42.7%) |
| Results for the three months of the current quarter | Net Sales ¥1,170 million / Operating profit ¥156 million / By segment FY2026 Q1 results for the accounting period: Chemicals, revenue of ¥62.8 billion and operating profit of ¥10.1 billion; Food, ¥21.4 billion and ¥800 million; Life Sciences, ¥31.0 billion and ¥4.4 billion; Other, ¥1.6 billion and ¥100 million, including the breakdown |
| Segment results | Chemicals Net Sales ¥628 million (YoY +20.0%) / Operating profit ¥101 million (YoY +60.9%) / Resin additives Net Sales ¥287 million (YoY +14.5%) / Operating profit ¥38 million (YoY +49.0%) / Semiconductor Materials Net Sales ¥108 million (YoY +47.2%) / Operating profit ¥26 million (YoY +82.9%) / Environmental materials Net Sales ¥232 million (YoY +16.9%) / Operating profit ¥35 million (YoY +60.1%) / Food Net Sales ¥214 million (YoY +4.2%) / Operating profit ¥8 million (YoY -21.6%) / Life Science Net Sales ¥310 million (YoY +14.6%) / Operating profit ¥44 million (YoY +36.9%) / Other Net Sales ¥16 million (YoY +9.9%) / Operating profit ¥1 million (YoY -38.4%) |
| Key KPIs | Indicator name Overseas revenue ratio / Value 55.9 % / Year on year against the same period last year Up from 54.6%, Indicator name Overseas revenue / Value ¥654 million / Year on year against the same period last year Up ¥9.9 billion year on year, Indicator name Overseas revenue in Asia / Value ¥305 million / Year on year against the same period last year Up ¥4.6 billion year on year, Indicator name Overseas revenue in the US, Europe, the Middle East and other regions / Value ¥348 million / Year on year against the same period last year Up ¥5.2 billion year on year |
Items this document does not state (24)
Ordinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesFull-year earnings forecastProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&ANew initiatives
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Changes in revenue and operating profit by segment are shown, but no specific reasons for the changes are provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.